Thibault, Gilles <br/><br/>
CD25 blockade in kidney transplant patients randomized to standard-dose or high-dose basiliximab with cyclosporine, or high-dose basiliximab in a calcineurin inhibitor-free regimen.  [electronic resource] 

 -  Transplant international : official journal of the European Society for Organ Transplantation  Feb 2016 
 - 184-95 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-2277 
<br/><br/><label>Standard No.: </label>10.1111/tri.12688  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Blocking--administration & dosage<br/>Antibodies, Monoclonal--administration & dosage<br/>Basiliximab<br/>Calcineurin Inhibitors--therapeutic use<br/>Cyclosporine--administration & dosage<br/>Female<br/>Graft Rejection<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Interleukin-2 Receptor alpha Subunit--immunology<br/>Kidney Transplantation<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Recombinant Fusion Proteins--administration & dosage